C700-2604 Screening compound: 1-{4-[(4-methylphenyl)methyl]-3-oxo-3H,4H-pyrido[2,3-b]pyrazin-2-yl}-N-(4-phenylbutan-2-yl)piperidine-3-carboxamide

C700-2604 Screening compound: 1-{4-[(4-methylphenyl)methyl]-3-oxo-3H,4H-pyrido[2,3-b]pyrazin-2-yl}-N-(4-phenylbutan-2-yl)piperidine-3-carboxamide
C700-2604 Screening compound: 1-{4-[(4-methylphenyl)methyl]-3-oxo-3H,4H-pyrido[2,3-b]pyrazin-2-yl}-N-(4-phenylbutan-2-yl)piperidine-3-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound C700-2604
1-{4-[(4-methylphenyl)methyl]-3-oxo-3H,4H-pyrido[2,3-b]pyrazin-2-yl}-N-(4-phenylbutan-2-yl)piperidine-3-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

C700-2604

Molecular Formula

C31H35N5O2 (C31 H35 N5 O2)

Compound Name

1-{4-[(4-methylphenyl)methyl]-3-oxo-3H,4H-pyrido[2,3-b]pyrazin-2-yl}-N-(4-phenylbutan-2-yl)piperidine-3-carboxamide

IUPAC name

1-{4-[(4-methylphenyl)methyl]-3-oxo-3H4H-pyrido[23-b]pyrazin-2-yl}-N-(4-phenylbutan-2-yl)piperidine-3-carboxamide

SMILES

CC(CCc1ccccc1)NC(C(CCC1)CN1C1=Nc2cccnc2N(Cc2ccc(C)cc2)C1=O)=O

InChI

InChI=1S/C31H35N5O2/c1-22-12-15-25(16-13-22)20-36-28-27(11-6-18-32-28)34-29(31(36)38)35-19-7-10-26(21-35)30(37)33-23(2)14-17-24-8-4-3-5-9-24/h3-6,8-9,11-13,15-16,18,23,26H,7,10,14,17,19-21H2,1-2H3,(H,33,37)

InChI Key

COZDGYSHOSTHEF-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14786067

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

509.65

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

9.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

4.642

Distribution Coefficient, logD

4.642

Water Solubility, LogSw

-4.21

Polar Surface Area

60.339

Acid Dissociation Constant (pKa)

14.44

Base Dissociation Constant (pKb)

3.04

Number of Chiral Centers

2.00

Percent sp3 carbon bonding

35.50

C700-2604 in Drug Discovery

Included in Screening Libraries

MCL1 Targeted Library (12200 compounds)

Protein Kinases Inhibitors Library (36801 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Nervous system
  • Hemic and lymphatic
  • Cardiovascular
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with C700-2604 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound C700-2604?
Check Price and Availability of C700-2604, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of C700-2604 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for C700-2604
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for C700-2604
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of C700-2604 available by request